BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2012
View Archived Issues
SIRT1 activation investigated in models of obesity
Read More
Novel data reported on GKM-001 in diabetes and obesity
Read More
Phase I results encourage continued clinical evaluation of PEGylated C-peptide
Read More
First-in-human data disclosed on gene-modified T cells to facilitate stem cell transplants
Read More
Roche presents novel LRRK2 inhibitors
Read More
Bristol-Myers Squibb patents novel inhibitors of CYP17
Read More
Novel diagnostics disclosed by Janssen Pharmaceuticals
Read More
Merck & Co. reports new CGRP receptor antagonists
Read More
New PI3K inhibitors developed in U.S.
Read More
Synta Pharmaceuticals prepares new IL-2/CRAC-targeted products
Read More
Pharmanest launches phase II study of SHACT
Read More
Eltoprazine study in Parkinson's disease meets primary objective
Read More
Summit achieves milestone in development of SMT-C1100
Read More
Novel dipeptidyl peptidase IV inhibitor shows promise in diabetes/obesity models
Read More
Combination therapy shows surprising synergistic efficacy in Batten disease model
Read More
VaxInnate begins phase I H5N1 vaccine study
Read More
ImaginAb and BZL Biologics expand collaboration
Read More
Invega Sustenna formulation enters phase III trials
Read More
Greer reports data from phase III sublingual immunotherapy trial
Read More
Proof-of-concept study begins for Ampyra
Read More
Cempra starts phase II trial in gonococcal infections
Read More
Lead Tokai product receives FDA fast track status
Read More
Two first-in-class PolyMedix products receive approved generic names
Read More
Jazz Pharmaceuticals completes acquisition
Read More
FDA grants fast track status to synthetic ectodysplasin-A
Read More
Enrollment under way in NX-1207 trial in low-grade localized prostate cancer
Read More